SUMMARY Acute necrotising pancreatitis in rats was induced by injecting 5% sodium taurocholate into the pancreatic duct. Prostaglandin E2 (100 jg/kg subcutaneously twice) decreased the mortality rate from 100% to 60% (NS). When treatment with prostaglandin E2 was combined with simultaneous administration of either dazmegrel (UK 38 485, 50 mg/kg bodyweight) or Sibelium (Flunarizine R 14 950, 0.2 mg/kg body weight) a significant decrease in the mortality rate (p<005) was recorded. Dazmegrel is a selective thromboxane A2 synthetase inhibitor and prevents the formation of thromboxane A2. Flunarizine (a calcium entry blocker) decreases thromboxane A2 formation and also inhibits the effects of raised thromboxane A2 concentrations. As plasma thromboxane B2 (the stable metabolite of thrombbxane A2) concentrations increase and the plasma prostaglandin E2 concentrations decrease in acute necrotising pancreatitis in rats, the results of the present study indicate that these prostaglandins play a role in the pathophysiology of the disease. It is suggested that restoration of the balance in prostanoid concentrations will have a beneficial effect on the course of acute necrotising pancreatitis. 
Several reports have shown that prostaglandins protect visceral organs against a variety of noxious agents. ' The effect of prostaglandins on the pancreas in acute necrotising pancreatitis (ANP), however, remains controversial.2-7 Ischaemia and impairment of the pancreatic microcirculation may play an important role in the onset and course of the disease.' Thromboxane A2 (TXA2) is a strong vasoconstrictor and as such may be a mediator of ischaemia. We have shown that thromboxane B2 concentrations raised in ANP,90`though inhibition of TXA2 alone does not dramatically alter survival. 9 We have also shown that plasma concentrations of prostaglandin E2 (PGE2) decrease in ANP.'°PGE2 has vasodilatory and cytoprotective properties that may protect visceral organs, including the pancreas, against ischaemic damage."' The administration of exogenous PGE2, however, alone did not affect survival significantly."7 Survival time was recorded and survivors were killed after 72 hours. The amount of ascitic fluid was measured at the time of autopsy by weighing cotton rolls saturated with the fluid. The pancreas was removed, fixed in 4% formalin and embedded in paraffin. Sections were cut and stained with haematoxylin and eosin. The preparations were assessed by light microscopy The amounts of ascitic fluid for the different groups were compared using the Mann Whitney U test, the survival data using Fischer's test for 2 x 2 tables.
Results
The effect of treatment with PGE2 on mortality for rats with acute necrotising pancreatitis is shown in Table 1 . Control animals (group 1) exhibited a 100% mortality. Treatment with two doses of 100 ,tg/kg PGE2 (group 2) reduced mortality to 60%, an effect that was enhanced by adjuvant treatment with either dazmegrel (group 3) or flunarizine (group 4). According to Fischer's test, a significant difference for groups 3 and 4 with the control group was obtained in the first 36 hours, when the mortality rate was 40% (P<0.05).
Ascites developed in all animals that died within 72 hours. The largest amounts of ascitic fluid were found in rats that died in the first 36 hours. The volume of ascitic fluid was not decreased by treatment with PGE2, but after additional pretreatment with dazmegrel the decrease in fluid was statistically significant (P<0-05) ( Table 2) .
Light microscopy studies of the pancreas showed Reber' initially found a protective effect which he could not confirm in later studies with cats. Differences in experimental design might, at least partially, explain the discrepancies between results. It also is not known which dose of PGE2 will reach the inflamed pancreas in a sufficiently high concentration when given subcutaneously.
In the present study treatment with inhibitors of thromboxane A2 (dazmegrel, Flunarizine) together with the administration of PGE2 led to a significant improvement in survival rate (P<0-05). The 
